M
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Mary Price's research focuses on the study of immunoconjugates, particularly in the context of multiple myeloma. Her work has involved investigating the corneal toxicity associated with the immunoconjugate drug belantamab mafodotin, drawing from real-world clinical experiences across multiple institutions. Price has contributed to the scientific literature through publications detailing these findings. Her scholarly work has garnered citations, and she has an h-index of 1. Price collaborates with researchers at the University of Arkansas for Medical Sciences, including Sharmilan Thanendrarajan, Jaskirat Sethi, Samer Al Hadidi, and Carolina Schinke, with whom she has co-authored publications.
Metrics
- h-index: 1
- Publications: 2
- Citations: 15
Selected Publications
-
Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience (2022)
Collaboration Network
Top Collaborators
Meera Mohan
Medical College of Wisconsin (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Lisa Rein
Medical College of Wisconsin (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Nishanth Thalambedu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Yetunde Ogunsesan
University of Arkansas for Medical Sciences (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Munawwar Hussain
Winthrop Rockefeller Foundation
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Jaskirat Sethi
Winthrop Rockefeller Foundation
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Fatima Khan
University of Arkansas for Medical Sciences (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Sravani Gundarlapalli
Winthrop Rockefeller Foundation
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Lakshmi Yarlagadda
Winthrop Rockefeller Foundation (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Binod Dhakal
Medical College of Wisconsin (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Megan Shirey
University of Arkansas for Medical Sciences
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
David Warner
University of Arkansas for Medical Sciences (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Siegfried Janz
Froedtert Hospital (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Sabarinath Venniyil Radhakrishnan
Froedtert Hospital (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Similar Researchers
Based on overlapping research topics
Asis Shrestha
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Megan Shirey
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Jaskirat Sethi
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies
Cancer Treatment and Pharmacology
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Abdul Rafae
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Multiple Myeloma Research and Treatments
Pharmacological Effects and Toxicity Studies